Alzpath Announces New Funding From The Alzheimer's Drug Discovery Foundation (Addf) To Advance A Novel, Diagnostic Blood-Based Assay
Round Type
Funding Round
CarlsbadBiotechnologyHealth CareHealth DiagnosticsInvestors
Description
ALZpath, a leading developer of innovative diagnostic solutions for Alzheimer's disease, is proud to announce that they have received funding from the Alzheimer's Drug Discovery Foundation (ADDF)'s Diagnostics Accelerator to accelerate the clinical availability of ALZpathDx as a laboratory developed test (LDT). ALZpathDx is a novel, proprietary assay for blood-based measurement of phosphorylated tau at threonine 217 (pTau217), a highly accurate, diagnostic biomarker for Alzheimer's disease. The assay is performed on the Quanterix Simoa HD-X immunoassay analyzer.
Quick answer
ALZpath raised an undisclosed amount in a Funding Round round, dated July 18, 2023. Investors: The Association For Frontotemporal Degeneration, Charles And Helen Schwab Foundation, The Dolby Family, Mac Kenzie Scott, Jeff Bezos, Bill Gates and Addf Co Founder Leonard A. Lauder. ALZpath is based in Carlsbad, California, United States.
- How much did ALZpath raise?
- ALZpath raised an undisclosed amount in a Funding Round round on July 18, 2023.
- Who invested in ALZpath?
- The Association For Frontotemporal Degeneration, Charles And Helen Schwab Foundation, The Dolby Family, Mac Kenzie Scott, Jeff Bezos, Bill Gates and Addf Co Founder Leonard A. Lauder are named as investors in this round.
- What does ALZpath do?
- ALZpath is a passionate and focused group of medical researchers, healthcare professionals, and renowned group of scientific advisors dedicated to transforming the Alzheimer’s disease ecosystem through earlier..
- Where is ALZpath based and how big is it?
- ALZpath is based in Carlsbad, California, United States. Fundz records about 10 employees.
- Who are the decision-makers at ALZpath?
- Fundz holds 1 contact at ALZpath, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Diagnostics and Biotechnology around the same time
Companies in the same sectors as ALZpath that raised within 45 days of this round, from Fundz verified event records.
- WaveFront Dynamics Inc. raised $5M on August 24, 2023.
- FeelBetter raised $5.9M (Funding Round) on July 31, 2023.
- Aptitude raised an undisclosed amount (Funding Round) on July 24, 2023.
- CathVision raised $9M (Funding Round) on July 18, 2023.
- Parker Health raised $25M (Series A) on July 12, 2023.
- Quantum Cyber N.V. raised $5.5M on June 28, 2023.
Who to call at ALZpath, and when
A new round usually means ALZpath is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ALZpath raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ALZpath, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ALZpath. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ALZpath raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ALZpath raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.